Localized differences in caudate and hippocampal shape are associated with schizophrenia but not antipsychotic type by McClure, Robert K. et al.
Localized differences in caudate and hippocampal shape are
associated with schizophrenia but not antipsychotic type
Robert McClurea, Martin Stynera,b,*, Eric Maltbiea, Jeffrey Liebermand, Sylvain Gouttarde,
Guido Gerige, Xiaoyan Shic, and Hongtu Zhuc
aDepartments of Psychiatry, University of North Carolina, Chapel Hill, NC, 27599, USA
bComputer Science, University of North Carolina, Chapel Hill, NC, 27599, USA
cBiostatistics, University of North Carolina, Chapel Hill, NC, 27599, USA
dDepartment of Psychiatry, Columbia University, New York, NY 10032, USA
eScientific Computing and Imaging Institute, University of Utah, Salt Lake City, UT 84112, USA
Abstract
Background—Caudate and hippocampal volume differences in patients with schizophrenia are
associated with disease and antipsychotic treatment, but local shape alterations have not been
thoroughly examined.
Methods—Schizophrenia patients randomly assigned to haloperidol and olanzapine treatment
underwent MRI scans at 3, 6, and 12 months. The caudate and hippocampus were represented as
medial representations (M-reps); mesh structures derived from automatic segmentations of high
resolution MRIs. Two quantitative shape measures were examined: local width and local
deformation. A novel nonparametric statistical method adjusted exponentially tilted (ET)
likelihood, was used to compare the shape measures across the three groups while controlling for
covariates.
Results—Longitudinal shape change was not observed in the hippocampus or caudate when the
treatment groups and controls were examined in a global analysis, nor when the three groups were
examined individually. Both baseline and repeated measures analysis showed differences in local
caudate and hippocampal size between patients and controls, while no consistent differences were
shown between treatment groups.
Conclusions—Regionally specific differences in local hippocampal and caudate shape are
present in schizophrenic patients. Treatment related longitudinal shape change was not observed
within the studied timeframe. Our results provide additional evidence for disrupted cortico-basal
ganglia-thalamo-cortical circuits in schizophrenia.
Clinical trial information—This longitudinal study was conducted from March 1, 1997, to July
31, 2001, at 14 academic medical centers (11 in the United States, 1 in Canada, 1 in the
Netherlands, and 1 in England). This study was performed prior to the establishment of centralized
registries of federally and privately supported clinical trials.
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1. Introduction
Converging trends in the neuroimaging of schizophrenia have led to the research conducted
in this study. The first trend is the association of altered caudate volume with antipsychotic
treatment. Reduction in caudate volume has been reported in MRI studies of antipsychotic-
naïve, first-episode schizophrenia patients (Corson et al. 1999a; Keshavan et al. 1998; Levitt
et al. 2002; Shihabuddin et al. 1998), who should not exhibit effects associated with
treatment and disease chronicity, however findings are inconsistent (Chakos et al. 1994; Gur
et al. 1998a). Cross-sectional MRI studies suggest that treatment of schizophrenia with
typical antipsychotic medications can be, but is not always, associated with enlarged
caudate. Dose (Chakos et al. 1994) and treatment findings (Corson et al. 1999b; Keshavan et
al. 1994; Lieberman et al. 2005; Massana et al. 2005) have been observed over periods of
twelve to twenty-four months in longitudinal MRI studies. Treatment of schizophrenia with
atypical antipsychotics for extended periods is associated with decreases in caudate volume
(Corson et al. 1999b), although studies in rodents are not entirely consistent with the human
data (Andersson et al. 2002; Lee et al. 1999).
The second trend is the reduction of volume (McClure and Weinberger, 2001) and
deformation of shape (Csernansky et al. 1998, 2002) demonstrated in the hippocampus by
cross-sectional MRI studies in schizophrenia. The size of the hippocampus is reduced at
onset of the first episode of psychosis, before the effects associated with treatment and
disease chronicity should occur (Lieberman et al. 2001; Szeszko et al. 2003; Velakoulis et
al. 1999). Longitudinal MRI studies over treatment periods of two to two and a half years
have shown hippocampal and temporal lobe volumes decrease (Gur et al. 1998b; Mathalon
et al. 2001), though not all studies show such changes (Lieberman et al. 2001). The
inconsistent findings should be viewed in the context of the common (Davis et al. 1998;
Delisi et al. 1988, 1992, 1995, 1997; Gur et al. 1998b; Jacobsen et al. 1998; Lieberman et al.
2005; Rapport et al. 1997), but not ubiquitous (Garver et al. 2000; Lieberman et al. 2001)
observation that regional grey and white matter volumes can decrease while CSF volumes
increase in longitudinal schizophrenia studies. There have also been some reports of an
association between hippocampal volume and antipsychotic type. In a cross-sectional MRI
study, treatment with atypical antipsychotics was associated with larger hippocampal
volumes than treatment with haloperidol, but the relationship was observed only in male
patients early in the course of their illness (Chakos et al. 2002). In a longitudinal MRI study,
first-episode schizophrenic subjects given haloperidol demonstrated more decreases in gray
matter volume than those given olanzapine after 24, 52 and 104 weeks of treatment
(Lieberman et al. 2005). While it is possible that antipsychotic type is associated with
differences in hippocampal volume change, there is not conclusive evidence yet.
The third trend is the emergence of medial representations (M-reps); a shape analysis
method providing information on a rich set of features not accessible by conventional
volume-based morphometry (Fletcher et al. 2003; Han et al. 2005; Pizer et al. 2005). MRI
studies performed at the UNC Neuro Image Research and Analysis Laboratory using these
high-dimensional statistical descriptions of shape in lateral ventricles (Styner et al. 2003,
2005) and hippocampi (Styner et al. 2004), have demonstrated effects of genetic relatedness
and schizophrenia, as well as a main effect of antipsychotic type in hippocampal shape of
male schizophrenia patients (Chakos et al. 2002).
McClure et al. Page 2













This investigation examined caudate and hippocampal shape in schizophrenia patients
randomly assigned to treatment with haloperidol or olanzapine. The specific purpose of the
study was to determine if shape differences in the caudate and hippocampus of
schizophrenia patients emerge following treatment. The specific outcome measures were
two quantitative shape measurements: radius and position. These two shape measurements
for the caudate and hippocampus were defined through M-reps with the radius measurement
quantifying the local width at an M-rep node(represented in Figure 1 by the length of a thin
rod projecting from a sphere) and the position measurement quantifying local deformation
at an M-rep node (represented in Figure 1 by the location of a sphere).
The following questions were addressed: do haloperidol-, olanzapine-treated patients, and
healthy control groups—globally (3-group comparison) or individually (comparisons
between each group)—differ at baseline or in a repeated measures analysis (considering data
from all time points but not longitudinal changes)? Over time, does shape change emerge
globally among or individually between, the three groups? According to the a priori
hypotheses, the following results were expected for shape measures in the hippocampus and
caudate: (1) at baseline, an effect of diagnosis between schizophrenia patients and controls;
(2) in the repeated measures analysis, an effect of diagnosis between schizophrenia patients
and controls; (3) at baseline as well as in the repeated-measures analysis, no effect of
antipsychotic type between schizophrenia patients in the two treatment groups; (4) in the
global and individual group comparisons, differences will emerge over time.
2. Materials and Methods
Subjects were enrolled in a randomized, multi-site, double-blind study (Lieberman et al.
2005) that was conducted from March 1, 1997 to July 31, 2001 at 14 academic medical
centers (11 in the United States, 1 in Canada, 1 in the Netherlands, and 1 in England).
In this study, 238 first-episode schizophrenia patients were enrolled. After random allocation
at baseline, 123 patients were selected to receive the conventional antipsychotic haloperidol
(2–20 mg/d), and 115 were selected to receive the atypical antipsychotic olanzapine (5–20
mg/d). Patients were treated and followed for up to 47 months. Fifty-six psychiatrically
healthy subjects were matched to the patients' demographic characteristics and enrolled as
control subjects (see Table 1 and Table 2). High resolution MRI (multi-site SPGR T1
weighted imaging on 1.5 Tesla scanners at 0.9375 × 0.9375 × 1.5mm resolution) was
performed at baseline and after 3, 6, and 12 months (Lieberman et al. 2005). A small set of
scans were performed after 24 months which were not considered in this study. Standardized
geometric phantoms were scanned twice per month to ensure geometric acuity and minimize
scanner bias across the 14 medical centers.
Prior to structural segmentation, the baseline MRI scans were rigidly aligned (mutual
information based registration) to a standard coordinate space and follow up MRI scans
were globally, affinely aligned to their baseline data. This setup minimizes inherent effects
due to changes over time in MR field-of-view (FOV) size or MR field inhomogeneity. In
particular, we analyzed FOV variation across time by studying changes in scale-factors
computed with affine co-registration of longitudinally paired geometric phantom
acquisitions. These scale-factor measurements allowed us to estimate that within-site FOV
size varied by as much as 3% over time, both within-slice-plane as well as out-of-plane,
necessitating an affine alignment to correct for these FOV distortions. Not surprisingly these
FOV variations varied across site, and thus affine alignment also reduces this site-specific
bias.
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Caudate and hippocampus structures were then segmented from the aligned MRI scans with
an automated atlas based segmentation tool developed in-house called AutoSeg (Gouttard et
al. 2007). Caudate and hippocampus shape were next represented as a medial mesh of
sampled nodes via a statistically-constrained based fit of a prior medial mesh model into the
binary segmentations (Pizer et al. 2009; Styner et al. 2003).
Figure 1 illustrates the medial mesh for both structures with the associated medial node
labeling used in the result section. Shape was captured as local width (medial width/radius)
and local deformation (medial deformation) as proposed by Carracso et al. (2000). While
local size is independent of pose, appropriate local deformation analysis necessitates a prior
alignment. Alignment was performed for the caudate and hippocampus independently, via
an extension of the standard rigid Procrustes alignment to medial structures (Gorczowski et
al. 2010).
The aim of our study was to investigate differences in medial width and deformation of the
hippocampus and caudate across the three groups (haloperidol-treated, olanzapine-treated,
and controls) while controlling for other covariates of interest. We utilized a novel
nonparametric method called adjusted exponentially tilted (ET) likelihood, along with a
likelihood ratio test for hypothesis testing (Zhu et al. 2009). Assuming only a set of
estimating equations, the adjusted ET likelihood is a nonparametric extension of general
linear mixed models and generalized estimating equations. This extension of the ET method
as a nonparametric method is particularly desirable for the analysis of brain morphometry
because the distribution of the morphometric measures often deviates from the Gaussian
distribution. For this study, the Shapiro-Wilk normality test was applied to check this
parametric assumption at each atom for both left and right hippocampi and caudate using the
residuals. It turned out that the Shapiro-Wilk test rejected the normality assumption at many
atoms of both structures on each side; therefore our nonparametric adjusted ET method is
preferred for the analysis of this data.
We first tested the a priori hypothesis at baseline. We used the adjusted ET likelihood to
calculate regression parameter estimates and then tested for group differences (Zhu et al.
2009). Specifically, at each atom, we considered the moment model based on the 28×1
estimating function. The dependent variables were local width and local deformation,
determined at 24 hippocampal nodes and 21 caudate nodes using M-reps (see Figure 1).
Covariates of interest were WBV (whole brain volume = CSF, white matter and gray
matter), ethnicity, age, gender, group (the two schizophrenia groups and the healthy control
group), and time. The adjusted ET likelihood ratio statistic is used to test hypothesis of
interest. Please see Zhu et al. (2009) for detailed analysis.
The false discovery rate approach was then used to correct for multiple comparisons in all
atoms for each structure (Benjamini and Hochberg, 1995). Secondly, we performed
longitudinal data analyses (Liang and Zeger, 1986). Again, we used the adjusted ET
likelihood coupled with the generalized estimating equations for longitudinal data to
estimate the regression parameters and then tested for specific group differences. In the
longitudinal analysis, we used the similar set of estimating equations as those in the baseline
analysis. Based on our previous analysis in Shi et al. (2011), we treated WBV as type II
covariate and adjusted the estimating equations slightly. Please see Shi et al. (2011) for
detailed analysis.
McClure et al. Page 4














3.1 Hippocampal Shape: Local Width and Local Deformation(See Fig 2)
The longitudinal analysis did not reveal significant changes in either local width or
deformation in the hippocampus (see Tables 3 and 4). The longitudinal global comparison
demonstrated a Group × Time interaction of width at nodes M8, C2, C3, and L6 in the left
hippocampus (see Figure 1), but only marginally reached statistical significance (Table 3).
Longitudinal analysis of the individual groups demonstrated no effect of time for local width
in any region of the left hippocampus (Table 3). Neither the global nor the individual group
comparisons, demonstrated an interaction of Group × Time or an effect of Time with respect
to local deformation of the left hippocampus longitudinally (see Table 4). Longitudinal
analysis also failed to show any Group × Time interaction or an effect of Time with respect
to local width or deformation in the right hippocampus (see Tables 3 and 4).
At baseline and in repeated measures analysis (using measurements from all the time
points), patients demonstrated significantly reduced node width (meaning a significantly
reduced local volume near the node location) when compared to controls (see Tables 5, 6, 7,
and 8). Significant baseline differences in width were observed in comparison of the
haloperidol-treated patients and controls, localized to node M8, C3, C4, and C5 in the left
hippocampus. The repeated measures analysis of haloperidol-treated patients compared to
controls revealed significant differences in width at nodes M8, C3 and C4 in the left
hippocampus. Significant differences in width were observed in the baseline analysis
comparison of olanzapine-treated patients to controls, located at nodes C4 and C5 of the left
hippocampus. Repeated-measures analysis of olanzapine-treated patients compared to
controls did not show significant differences in width at any left or right hippocampal
region. As expected, neither the baseline nor the repeated-measures analysis showed any
significant differences in width between haloperidol and olanzapine-treated patients for the
left hippocampus.
In both the baseline and the repeated-measures analysis, each patient group showed local
differences in hippocampal deformation at the medial nodes compared to controls (see
Tables 7 and 8). Haloperidol-treated patients compared to controls, showed differences in
local deformation throughout medial, central, and lateral regions of the left hippocampus in
both the baseline and repeated-measures analyses. In the baseline analysis only, the
olanzapine-treated patients showed differences from controls in local deformation in medial,
central, and lateral nodes for the left hippocampus, overlapping with the nodes showing
differences in the comparison of haloperidol-treated patients to controls. However in the
repeated-measures analysis, olanzapine-treated patients compared to controls showed
differences in local deformation in only a few left hippocampal nodes (M8, C1, and L4).
No significant differences in local deformation of the left hippocampus were observed
between haloperidol- or olanzapine-treated patients in the baseline or repeated-measures
analyses (Tables 7 and 8). In the right hippocampus, differences in local deformation were
observed in the repeated measures analysis between haloperidol-treated patients and controls
at nodes M1, M7, M8, C1, C3, C6, C7, L2, and L7, but no differences in local deformation
were noted in the right hippocampus between either the olanzapine-treated patients and
controls or the olanzapine and haloperidol-treated patients.
3.2 Caudate Shape: Local Width and Local Deformation (See Fig 3)
There was little evidence for significant longitudinal caudate shape change in local width or
deformation (see Tables 9 and 10). Global comparison of the three groups in the longitudinal
analysis demonstrated a Group × Time interaction in local width of the left caudate at nodes
S5 and I1 (see Fig 1), but these findings only marginally reached statistical significance. No
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effect of Time was observed in local width at any node in the individual group analysis. In
the right caudate, the longitudinal global comparison demonstrated a Group × Time
interaction in local width at nodes S1, S4 and I2, but again no effect of Time was observed
in the individual group analysis. Longitudinal analysis of deformation did not show
significant effects in either left or right caudate and no Group × Time interaction was
observed.
The baseline and repeated measures analyses of left and right caudate width showed highly
similar results with respect to regional specificity (Tables 11, 12). While no left caudate
width differences were observed between any groups, haloperidol-treated patients compared
to controls showed significant differences in right caudate width for nodes S4 and I7 at
baseline. The repeated measures analysis also showed right caudate width differences at
node I7. Similarly, olanzapine-treated patients compared to controls had significant right
caudate width differences at node S4 at baseline, but not in the repeated measures analysis.
No significant differences in the right caudate were observed between treatment groups.
The repeated measures analyses of local deformation in patient groups compared to controls
showed widespread differences in the caudate (Tables 13 and 14). In the baseline analysis,
haloperidol-treated patients showed differences from controls in deformation of the left
caudate at nodes S2–8, C1, C3, C4, and I1–I6, which was also reflected in the repeated
measures analysis where they showed significant differences in deformation of nodes S2,
S5, S6, C3, I1, I2 and I6. Compared to controls, olanzapine-treated patients displayed
differences in deformation in left caudate nodes S2–5, C1, C4, I1–4, I6, and I7. One superior
node in the left caudate (S2) showed differences in deformation when the haloperidol-
treated and the olanzapine-treated patients were compared (Table 14), but this finding was
regionally isolated and no difference in width was observed. Repeated measures analysis of
right caudate deformation demonstrated similar differences between treatment groups and
controls. Differences in local deformation were observed in haloperidol-treated patients at
nodes S2–6, C1, C5, I1–6 and in olanzapine-treated patients at nodes S1–5, C1 and C2, C5,
I1–I4, I6 and I7. No differences in deformation were noted in the right caudate between
treatment groups (Table 14).
4. Discussion
Longitudinal changes in local width and deformation were not observed globally or when
the haloperidol-treated, olanzapine-treated, and control groups were examined individually.
While no differences were found between the treatment groups for the caudate or
hippocampus, both treatment groups showed significant differences from controls. The
baseline analysis demonstrated differences in local width of the left hippocampus at central-
middle areas between both treatment groups and controls with the repeated measures
analysis showing the same result for only the haloperidol-treated patients. Differences in
local deformation between each treatment group and controls were observed at baseline in
the left hippocampus at anterior, middle, and posterior nodes. Furthermore, at baseline
haloperidol-treated patients and controls also showed differences in local deformation for
anterior and posterior nodes of the right hippocampus. These baseline hippocampal shape
differences are expected as previous studies have found differential hippocampal volumes
for first episode schizophrenic patients (Lieberman et al. 2001; Velakoulis et al. 1999) with
Szeszko et al. (2003) specifically finding reduced volume for the anterior hippocampus. A
previous study by Styner et al. (2004) in chronic schizophrenia patients reported significant
deformation differences in a few posterior (tail) nodes after normalization for hippocampal
size differences.
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Baseline and repeated measures analyses demonstrated differences in local deformation
between patients and controls at several superior and inferior nodes of both the right and left
caudate, with considerable regional overlap between the treatment groups. These broad
deformation differences were expected as other studies have shown similar differences to be
present in anti-psychotic naïve schizophrenics (Ballmaier et al. 2008) and even in the
unaffected siblings of schizophrenia patients (Mamah et al. 2008). Local width differences
between patients and controls were seen at baseline only for the right caudate and only in
isolated superior (S4) and head (I7) regions. This finding is particularly consistent with
those of Levitt et al (2009) which showed a very similar pattern of significant isolated local
shape differences for males with schizotypal personality disorder that appeared only in the
right caudate using a surface based shape analysis. While such a surface based analysis can
provide a higher degree of locality, it cannot separate changes in local width (growth or
shrinkage) from changes in local deformation as our M-Rep method can. See Styner et al.
(2004) for a more detailed comparison of these two methods of shape analysis.
Surprisingly, significant differences in shape change were not observed over time between
haloperidol- and olanzapine-treated patients. There are several potential explanations for
why our primary hypothesis was not supported. First, the results could be false-negative, and
while significant shape differences did emerge between the treatment groups, our methods
did not detect them. This is possible but unlikely, given that shape differences were
observed at baseline between controls and schizophrenics, with considerable regional
overlap between the two treatment groups. Second, it is possible our results are true
negative. The structural changes in the caudate associated with antipsychotic treatment are
small in size and not seen in every study (Mamah et al. 2007; Tauscher-Wisniewski et al.
2002). Third, although shape measures are thought to be more sensitive than volume
measures, the shape change associated with antipsychotic treatment may be smaller than
volume changes, and undetectable using the M-reps method. Fourth, unidentified
confounding factors may have masked the effects of antipsychotic treatment. Confounding
factors certainly could have masked actual shape change, since it is not possible to match
subjects on every factor that may alter brain structure. Several factors may have altered the
brain structures measured with MRI in this population: disease progression (McClure and
Lieberman, 2003); external environmental events associated with schizophrenia such as
changes in tissue perfusion, fat content, and water content; changes in the neuronal and non-
neuronal tissue compartments in the brain (Weinberger and McClure, 2002). Other
potentially confounding factors not controlled for in this study include hydration status,
body weight, illness severity, and previous treatment with antipsychotic medication.
This study is the first large-scale analysis that specifically examines longitudinal changes in
local width and deformation in schizophrenia patients treated with typical and atypical
antipsychotics using the M-reps method. The absence of shape differences at baseline
between schizophrenia patients randomized into treatment groups indicates that our
execution of the M-reps method was stable and reliable. Differences in the shape of the
hippocampus and caudate between schizophrenic patients and controls using these methods
is a novel finding, though not unexpected. There is extensive evidence of anatomical
specificity in connections between the basal ganglia, hippocampus, and cerebral cortex
(Draganski et al. 2008). There is also evidence from functional neuroimaging studies
suggesting the presence of dysfunctional prefrontal-hippocampal (Callicott et al. 2003) and
prefrontal-basal ganglia (Morey et al. 2008) circuits in schizophrenia. Demonstrating a
direct relationship between dysfunction of specific circuits and altered morphometry of the
caudate and hippocampus would provide additional evidence for the disruption of those
circuits in schizophrenia.
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Visualization of the medial representation grid and node labeling for right caudate (left,
labeled from a medial view) and hippocampus (right, labeled from the top view). Labels: S =
Superior, C = Central, I = Inferior, M = Medial, L = Lateral. Increasing numerical value
means going from a posterior to an anterior location. Local radius is represented by the
length of the thin rods projecting from the node points, the node width. Local position is
represented by the location of the node points measuring local deformation.
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Visualization of local significance in medial position and width in the hippocampus. Left:
Baseline group effect only (without repeated measures), Right: Full group effect. P-values
are visualized from cyan (p=0.1) to yellow (p=0.001). All maps are corrected for multiple
comparisons.
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Visualization of local significance in medial position and radius in the caudate. Left:
Baseline group effect only (without repeated measures), Right: Full group effect. P-values
are visualized from cyan (p=0.1) yellow (p=0.001). All maps are corrected for multiple
comparisons.
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Table 1
Demographic Characteristics of Patients and Controls at Baseline
Age (years) Baseline Whole Brain Volume
(liters)
Mean SS.D. Mean SS.D.
Haloperidol 24.14 4.89 1.335 0.129
Olanzapine 23.56 4.63 1.330 0.143
Controls 25.28 3.97 1.368 0.127
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